{"retracted":false,"update":{"timestamp":1411084800000,"doi":"10.1007/s00259-014-2918-0","type":"correction"},"doi":"10.1007/s00259-014-2841-4","journal":"European Journal of Nuclear Medicine and Molecular Imaging","publisher":"Springer Nature","title":"Erratum to: Do CSF levels of t-Tau, p-Tau and β1–42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease"}
